Development of biomarker predicting the response of immunotherapy for patients with urothelial cancer using urine miRNA
Not Applicable
Recruiting
- Conditions
- urothelial cancer
- Registration Number
- JPRN-UMIN000047198
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1, patients with history of using immunotherapy for urothelial or non-urothelial carcinoma before the registration of this study. 2, patients with other cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method